Suvorexant or placebo and brain dopamine in people with alcohol use
About this title
Read the official source — NCT06484075Understand this study
Who could participate?
Listed age limits: 18 years to 75 years.
What will I do during this study?
Participants receiving alcohol-withdrawal treatment stay on the clinical unit and are assigned suvorexant or placebo (an inactive comparison treatment) alongside usual care, with movement monitoring, blood tests and thinking assessments. Brain imaging includes two PET scans and one MRI (magnetic resonance imaging). Healthy volunteers form a separate imaging group without study treatment.
- Listed locations
- BethesdaSee all locations and recruitment
- Study phase
- Phase 1 / Phase 2This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
What to know before participating
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 180
- Sponsor
- National Institute on Alcohol Abuse and Alcoholism (NIAAA)
- Sponsor type
- Research institute
- Study type
- Drug
- Intervention type
- Device, Drug
- Study phase
- Phase 1 / Phase 2This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
- Locations
- United States
- Age range
- From 18 Years to 75 Years
- Official registry ID
- NCT06484075
- Official title
Show the full official title
Suvorexant for Alcohol Use Disorder (AUD): Neural Mechanisms
Recruitment & locations
Bethesda
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is National Institute on Alcohol Abuse and Alcoholism (NIAAA), a research institute.
Does this study involve medication?
Yes. The study involves medication, including Suvorexant and Placebo.
Who can participate?
Listed age limits: 18 years to 75 years.
Is this study still recruiting?
The registry lists this study as recruiting.
